We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Info:
#YGEN @Yourgene_Health
Yourgene Health’s Chief Operating Officer will be discussing the Company’s response to the #Covid19 #Coronavirus crisis tomorrow, Tuesday 7th April at 4pm BST. Register here for the #BruntwoodSciTech Webinar – Adapting During Crisis
https://twitter.com/ColdHotand/status/1247096111271161858?s=19
Powering ahead - 17.5p + 1.63p 10.2%
Could 17's soon be in the rear mirror?
Suspect they are full out in the lab at present with important implications for revenue and cash flow.
A 200k buy just went through at 17.28
Indeed fundamentals are sound, started this half with £4.1m in cash, primary expense was acquisition of Elucigene which is now accretive and adding to the bottom line. Admin expenses have been synergised. Profit increased 141% to £4.1m, that’s cash! They are confident of hitting £17m in revenues year end. I maintain that they still had enough head room in the system to scale up virtually capex free to take on PHE and NCYT, that’s a result of cost savings and smarter working. We have £17m of revenue + two other work streams, sure they won’t be in this year’s numbers but they will be in the outlook. Remember YGEN hit their ebit and loss per share now evens. This is going one way. At the end of the day ideas are great but it’s delivery and numbers that drive the sp longer term. And we have a seller, for whatever reason, probably balancing books at end of tax year for losses elsewhere, given up on equities who knows but what an opportunity for us nimble PI’s that can just built a holding here over time! And over 7m traded today! Not long now then I reckon a 5p step up! All imo with the kitchen sink thrown in as well!
Trek
Fundamentals will win the day here.Just thank the seller for keeping the price down
That’s another 20292 from me. When the business is sound buy against the seller. I bought VRS at 13p when Miton was selling, PI’s just kept piling in then boom! It went straight to 30p and then on from there. Imo same gonna happen here.
Trek
Would be nice if we get to see the back of 16 and 17p.